Skip to main content
Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
19.01
-0.28 (-1.45%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Monte Rosa Therapeutics Revenue

In the year 2025, Monte Rosa Therapeutics had annual revenue of $123.67M with 63.54% growth. Monte Rosa Therapeutics had revenue of $2.78M in the quarter ending December 31, 2025, a decrease of -95.41%.

Revenue (ttm)
$123.67M
Revenue Growth
+63.54%
P/S Ratio
12.30
Revenue / Employee
$824,480
Employees
150
Market Cap
1.52B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025123.67M48.05M63.54%
Dec 31, 202475.62M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Ardelyx 407.32M
Immunocore Holdings 400.02M
Wave Life Sciences 71.80M
Intellia Therapeutics 67.67M
Nuvation Bio 62.90M
Immatics 56.67M
Agios Pharmaceuticals 54.03M
Generate Biomedicines 31.89M
Revenue Rankings

GLUE News

More News